These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10257925)

  • 1. Cost, motion, and time studies comparing a new cephalosporin admixture system.
    Turco SJ
    Hosp Pharm; 1982 Dec; 17(12):653-8. PubMed ID: 10257925
    [No Abstract]   [Full Text] [Related]  

  • 2. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM; Daniels CE; Somani SM
    Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of wastage in a hospital intravenous admixture program.
    Salberg DJ; Newton RW; Leduc DT
    Hosp Formul; 1984 May; 19(5):375-8. PubMed ID: 10266241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and time required to add potassium chloride to large-volume parenterals.
    Turco SJ
    Hosp Pharm; 1979 Dec; 14(12):718-9. PubMed ID: 10309084
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of premixed and non-premixed potassium chloride large-volume parenterals.
    Turco SJ
    Hosp Pharm; 1979 Dec; 14(12):720-2. PubMed ID: 10309085
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of parenteral cephalosporin regulation on pharmacy costs.
    Ryan JL; Francese J
    Hosp Formul; 1983 May; 18(5):510-2. PubMed ID: 10260198
    [No Abstract]   [Full Text] [Related]  

  • 7. Automatic pipetters: applications and cost considerations in I.V. admixture programs.
    Blackstone M; Hauser LD
    Hosp Mater Manage Q; 1980 Feb; 1(3):69-85. PubMed ID: 10309094
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacy services: I. Time and cost study in a medical center hospital.
    Schwartz JI; Swanson LN
    Hosp Formul; 1975 Dec; 10(12):582-4. PubMed ID: 10237824
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlling admixture waste through pharmacist monitoring.
    Adachi WD; Endo AY; Tanaka JY
    Am J Hosp Pharm; 1984 May; 41(5):883. PubMed ID: 6731449
    [No Abstract]   [Full Text] [Related]  

  • 10. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Justification of a pharmacy intravenous admixture service in an Australian hospital.
    Plumridge RJ; Maher M
    Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cephalosporin cost reduction.
    Martucci HJ; Parry MF
    Hosp Formul; 1981 Apr; 16(4):396-8, 403. PubMed ID: 10250718
    [No Abstract]   [Full Text] [Related]  

  • 13. Concurrent monitoring of third generation cephalosporins.
    Freedy HR; Simonelli RJ
    Am J Hosp Pharm; 1986 Jan; 43(1):140-1. PubMed ID: 3953582
    [No Abstract]   [Full Text] [Related]  

  • 14. Recycled unused piggyback admixtures through the use of tamper-proof safety caps.
    Jennings RH; Schad RF; Kaurich J
    Hosp Pharm; 1982 Dec; 17(12):643-5, 652. PubMed ID: 10257924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case studies of pharmacy involvement in hospital-based home health care. Hamot Medical Center.
    Meyer JD; Brundige ML; Kelly WN
    Am J Hosp Pharm; 1986 Feb; 43(2):406-9. PubMed ID: 3953605
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacist impact on parenteral cephalosporin prescribing.
    Lawlor MC; Lucarotti RL
    Hosp Formul; 1983 Apr; 18(4):402-4, 407-8. PubMed ID: 10259512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial impact of formulary revision of second-generation cephalosporins.
    Andrews JD; Hafting S
    Can J Hosp Pharm; 1988 Jun; 41(3):125-7. PubMed ID: 10288499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microinfusion: clinical and cost-containment concepts.
    Webb JW; DeMonaco HJ; Shamsi S
    Hosp Pharm; 1985 Dec; 20(12):896-9, 903. PubMed ID: 10274575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy-initiated implementation of a syringe pump infusion system.
    Goudreau JB; Morrissey JM
    Am J Hosp Pharm; 1985 Mar; 42(3):584-7. PubMed ID: 3985022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculation of product waste in i.v. admixture programs.
    Vogel DP; Eck TA; Witte KW
    Am J Hosp Pharm; 1986 Apr; 43(4):952-3. PubMed ID: 3706344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.